PEOPLE - MediSpectra (US) makes appointment:
This article was originally published in Clinica
MediSpectra, a US developer of optical biopsy technology for cervical cancer detection, has appointed Dr David Lipson vice-president of product development. Dr Lipson was formerly director of research and development at Medtronic.
You may also be interested in...
Switzerland’s SIX exchange-listed drug development company, Basilea, is moving two new oncology candidates along its R&D pipeline, supported by strong revenues from two partnered anti-infective products.
Recommendations from the Alliance for Regenerative Medicine aim to improve cross-border healthcare to ensure patients can access advanced therapies.
At the OurCrowd Global Investor Summit in Jerusalem, Israel, on 13 February, Medtech Insight met wound care device company Nanomedic to find out more about its unique electro-spinning technology.